Skip to content

DMT: all studies

Page 19 of 160: studies 181 to 190 of 1,593, newest first. Back to the DMT overview

Research

Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT).

European Journal of Pharmaceutical Sciences August 1, 2024 Christopher G Witowski, Mika R Hess, Nate T Jones et al. 7 citations

There is considerable evidence from the literature that psychedelics, such as N,N-dimethyltryptamine (DMT), are safe and effective treatments for depression. However, clinical administration to induce psychedelic effects and expensive psychotherapy-assisted treatments likely limit accessibility to the average patient. There is emerging evidence that DMT promotes positive behavioral changes in...

Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design.

Polymers July 29, 2024 Pablo Miranda, Analía Castro, Paola Díaz et al. 5 citations

We present the development and characterization of a nasal drug delivery system comprised of a thermosensitive mucoadhesive hydrogel based on a mixture of the polymers Poloxamer 407, Poloxamer 188 and Hydroxypropyl-methylcellulose, and the psychedelic drug 5-methoxy-N,-N-dimethyltryptamine. The development relied on a 3 × 3 Box-Behnken experimental design, focusing on optimizing gelification...

DOI: 10.3390/polym16152148 (opens in new tab) Full text (opens in new tab) Drug delivery systems Nasal drug administration Thermosensitive polymers Pharmaceutical formulations +7

Author Correction: 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats

Scientific Reports July 14, 2024 Annie C. Souza, Bryan C. Souza, Arthur França et al. 1 citation

The original version of this Article contained an error in Affiliation 6, which was incorrectly given as ‘Brain Network Dynamics Unit, University of Oxford, Oxford, UK.’ The correct affiliation is listed below:

Unlocking the Therapeutic Potential of DMT’s: Molecular Modelling Insights into Nueropharmacological Mechanisms and Clinical Prospects

Letters in Applied NanoBioScience June 30, 2024 Rishabh Khare, K. Rajagopal, Srikanth Jupudi et al.

Depression is a critical mental ailment as it impacts about 5% of the global population, prompting scientists to create more efficacious antidepressants. The monoamine-deficiency hypothesis suggests that depression is caused by the depletion of certain neurotransmitters like serotonin, norepinephrine, and dopamine in the brain, where serotonin plays the most critical role among all and has been...

5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood—a retrospective case study

June 7, 2024 Mika Turkia 1 citation preprint

5-MeO-DMT is a psychedelic substance with a short duration of action and intensive effects. Its therapeutic efficacy and practicality may significantly surpass those of classical psychedelics such as ayahuasca and LSD. This retrospective ethnographic inquiry features a woman in her mid-thirties who witnessed her mother's violent suicide and its bloody aftermath at the age of three. Before and...

DOI: 10.31234/osf.io/bvk2f (opens in new tab) Sexual abuse Compassion Neglect Facilitator +2

Ayahuasca: N, N-dimetiltriptamina (DMT) una Herramienta Psicodélica con Posibles Propiedades Psicoplastogénicas

Revista de Investigación Científica y Tecnológica June 2, 2024

Ayahuasca, un té utilizado inicialmente por pueblos amerindios, con fines medicinales, religiosos y sacramentales, y luego se difundió en muchas partes del mundo en contextos urbanos, que, además de su uso religioso y espiritual, también el uso recreativo. El té de ayahuasca contiene un perfil químico bien característico de compuestos alcaloides psicoactivos que son N, N-dimetiltriptamina (DMT)...

Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT

bioRxiv (Cold Spring Harbor Laboratory) May 31, 2024 Jakub Vohryzek, Selen Atasoy, Gustavo Deco et al. 8 citations preprint

Exploring the intricate relationship between brain's structure and function, and how this affects subjective experience is a fundamental pursuit in neuroscience. Psychedelic substances offer a unique insight into the influences of specific neurotransmitter systems on perception, cognition and consciousness. Specifically, their impact on brain function propagates across the structural...

DOI: 10.1101/2024.05.30.596410 (opens in new tab) Full text (opens in new tab) Connectome Consciousness Harmonics Perception +2

5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats.

Scientific Reports May 17, 2024 Annie C. Souza, Bryan C. Souza, Arthur França et al. 7 citations

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent classical psychedelic known to induce changes in locomotion, behaviour, and sleep in rodents. However, there is limited knowledge regarding its acute neurophysiological effects. Local field potentials (LFPs) are commonly used as a proxy for neural activity, but previous studies investigating psychedelics have been hindered by confounding...

DOI: 10.1038/s41598-024-61474-9 (opens in new tab) Full text (opens in new tab) 5-MEO-DMT Hippocampal oscillations Prefrontal cortex Psychedelics hallucinogens +5

Effect of Intravenous Delivery of N,N Dimethyltryptamine on Sleep-Wake States in Rat

Physiology May 1, 2024 Rachel Summerfield, Trent Groenhout, Tiecheng Liu et al.

Psychedelics, including N, N, Dimethyltryptamine (DMT), are being increasingly explored for therapeutic potential to treat psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder. These and other psychiatric conditions have a bidirectional relationship with sleep patterns but the impact of psychedelics, particularly DMT, on sleep architecture is incompletely...

N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.

Alzheimer's Research & Therapy May 1, 2024 Dan Cheng, Zhuo-Gui Lei, Kin Chu et al. 41 citations

Aberrant neuronal Sigma-1 receptor (Sig-1r)-mediated endoplasmic reticulum (ER)- mitochondria signaling plays a key role in the neuronal cytopathology of Alzheimer's disease (AD). The natural psychedelic N, N-dimethyltryptamine (DMT) is a Sig-1r agonist that may have the anti-AD potential through protecting neuronal ER-mitochondrial interplay. 3×TG-AD transgenic mice were administered with...

DOI: 10.1186/s13195-024-01462-3 (opens in new tab) Full text (opens in new tab) Alzheimer’s disease Er-mitochondria crosstalk N,N-Dimethyltryptamine Cognitive impairment +4